OPKO Health (OPK)
(Real Time Quote from BATS)
$1.40 USD
+0.01 (0.72%)
Updated Sep 17, 2025 03:16 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPK 1.40 +0.01(0.72%)
Will OPK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPK
LH Stock Rises on Acquisition of BioReference Health's Select Assets
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
Other News for OPK
OPK forms 20 Day Moving Average Resistance on September 16
Fell Below 20 Day Moving Average appears for OPK after 1.43% move
Opko Health Sells BioReference Assets to Labcorp
Is OPK setting up for a drop? Bearish Engulfing shows up after sinking 2.1%
OPK forms Bollinger Band Squeeze on September 11